UBS O'Connor’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

UBS O'Connor’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,000,000	Closed	-$29.2M	–	739
2023 Q1	$29.2M	Buy	+2,000,000	New	+$28.3M	0.69%	23
2022 Q4	–	Sell	-2,000,000	Closed	-$13.8M	–	674
2022 Q3	$13.8M	Hold	2,000,000	–	–	0.16%	79
2022 Q2	$14M	Buy	+2,000,000	New	+$15.6M	0.15%	75
2022 Q1	–	Sell	-1,990,000	Closed	-$21.5M	–	533
2021 Q4	$21.5M	Hold	1,990,000	–	–	0.21%	44
2021 Q3	$24.1M	Hold	1,990,000	–	–	0.19%	43
2021 Q2	$24.1M	Hold	1,990,000	–	–	0.22%	40
2021 Q1	$27.7M	Hold	1,990,000	–	–	0.4%	27
2020 Q4	$28.2M	Buy	+1,990,000	New	+$26M	0.58%	24

UBS O'Connor's AMYT Position: Q2 2023 in Review

UBS O'Connor sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 2,000,000 shares — an estimated $29.2M sold.

UBS O'Connor first reported a position in AMYT in Q4 2020 and held it in 8 quarters. The position peaked at $29.2M in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

UBS O'Connor reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
UBS O'Connor sold 2,000,000 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $29.2M.
UBS O'Connor first reported a position in Amryt Pharma plc American Depositary Shares in Q4 2020 and held it in 8 quarters.
UBS O'Connor's Amryt Pharma plc American Depositary Shares position peaked at $29.2M in Q1 2023.
0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.